CIG
ABBV icon

Cascade Investment Group’s AbbVie ABBV Stock Holding History

Cascade Investment Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Hold
6,471
– – 0.91% 28
2026
Q1 		$1.41M Sell
6,471
-175
-3% -$38.8K 0.93% 29
2025
Q4 		$1.52M Sell
6,646
-205
-3% -$46.7K 1.01% 27
2025
Q3 		$1.59M Sell
6,851
-33
-0.5% -$6.72K 1.05% 24
2025
Q2 		$1.28M Buy
6,884
+25
+0.4% +$4.65K 0.89% 31
2025
Q1 		$1.44M Sell
6,859
-135
-2% -$26.2K 1.11% 25
2024
Q4 		$1.24M Sell
6,994
-170
-2% -$31.3K 0.89% 32
2024
Q3 		$1.41M Buy
7,164
+22
+0.3% +$4.11K 1.04% 24
2024
Q2 		$1.22M Buy
7,142
+116
+2% +$19.2K 0.96% 29
2024
Q1 		$1.28M Buy
7,026
+201
+3% +$34.6K 0.96% 30
2023
Q4 		$1.06M Buy
6,825
+142
+2% +$20.7K 0.85% 35
2023
Q3 		$996K Sell
6,683
-15
-0.2% -$2.2K 0.94% 32
2023
Q2 		$902K Buy
6,698
+46
+0.7% +$6.75K 0.83% 32
2023
Q1 		$1.06M Sell
6,652
-198
-3% -$30.3K 1.05% 25
2022
Q4 		$1.11M Buy
+6,850
New +$1.05M 1.15% 22

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Cascade Investment Group's ABBV Position: Q2 2026 in Review

Cascade Investment Group held its AbbVie (ABBV) position steady in Q2 2026 at 6,471 shares worth $1.63M. The position accounts for 0.91% of the portfolio, ranked #28.

Cascade Investment Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,201 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Cascade Investment Group held 6,471 shares of AbbVie worth $1.63M as of Q2 2026.
  • Cascade Investment Group left its AbbVie share count unchanged in Q2 2026.
  • AbbVie made up 0.91% of Cascade Investment Group's portfolio in Q2 2026, its #28 holding.
  • Cascade Investment Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,201 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Cascade Investment Group's 13F filing for Q2 2026, filed 23 Jul 2026.